1 – 10 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia
(
- Contribution to journal › Article
- 2015
-
Mark
Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity
(
- Contribution to journal › Article
- 2014
-
Mark
Prognostic Implications of Mutations in NOTCH1 and FBXW7 in Childhood T-ALL Treated According to the NOPHO ALL-1992 and ALL-2000 Protocols
(
- Contribution to journal › Article
- 2013
-
Mark
Outcome of poor response paediatric AML using early SCT
(
- Contribution to journal › Article
- 2012
-
Mark
Whole-exome sequencing of pediatric acute lymphoblastic leukemia.
(
- Contribution to journal › Article
-
Mark
Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004
(
- Contribution to journal › Article
- 2010
-
Mark
Assessment Of Chemotherapy-Induced Nausea And Vomiting In Children And Adolescents With Cancer
(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia
(
- Contribution to journal › Article
-
Mark
The DNA methylome of pediatric acute lymphoblastic leukemia.
(
- Contribution to journal › Article
-
Mark
B-cell precursor t(8;14)(q11;q32)-positive acute lymphoblastic leukemia in children is strongly associated with Down syndrome or with a concomitant Philadelphia chromosome.
(
- Contribution to journal › Article